Got $3,000? These 4 Emerging Coronavirus Vaccine Stocks Look Like a BargainThe Motley Fool • 09/05/20
CureVac Is Promised Up to $298 Million for Coronavirus Vaccine Development by GermanyThe Motley Fool • 09/04/20
Have $3,000? Buying These 3 Stocks Would Be the Smartest Move You Ever MadeThe Motley Fool • 08/29/20
Meet the Hot New Coronavirus Vaccine Stock That's Already Bigger Than Inovio and NovavaxThe Motley Fool • 08/19/20
CureVac Is Incredibly Overvalued And Perfectly Captures The Insanity Of The U.S. Stock Market In 2020Forbes • 08/18/20
U.S. IPO Weekly Recap: Coronavirus Vaccine Developer CureVac Pops 249% In A 4-IPO WeekSeeking Alpha • 08/15/20